| Is the BFM regimen feasible for the treatment of adult acute lymphoblastic leukemia? A retrospective analysis of the outcomes of BFM and hyper-CVAD chemotherapy in two centers I Alacacioglu, SS Medeni, GH Ozsan, B Payzin, OG Sevindik, C Acar, ... Chemotherapy 60 (4), 219-223, 2015 | 33 | 2015 |
| Can Neutrophil‐to‐Lymphocyte Ratio, Monocyte‐to‐Lymphocyte Ratio, and Platelet‐to‐Lymphocyte Ratio at Day+ 100 be used as a prognostic marker in Multiple Myeloma patients with … S Solmaz Medeni, C Acar, A Olgun, A Acar, A Seyhanlı, E Taskıran, ... Clinical Transplantation 32 (9), e13359, 2018 | 27 | 2018 |
| Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma? S Solmaz, O Uzun, C Acar, OG Sevindik, O Piskin, HG Ozsan, F Demirkan, ... Journal of laboratory physicians 10 (04), 363-369, 2018 | 21 | 2018 |
| Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities OG Sevindik, Z Guc, S Kahraman, S Medeni Solmaz, A Katgi, C Acar, ... Leukemia & Lymphoma 56 (9), 2552-2555, 2015 | 21 | 2015 |
| Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: real‐world data E Birtas Atesoglu, Z Gulbas, A Uzay, M Ozcan, F Ozkalemkas, MS Dal, ... Hematological oncology 41 (4), 663-673, 2023 | 20 | 2023 |
| The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma S Solmaz, O Uzun, OG Sevindik, F Demirkan, MA Ozcan, GH Ozsan, ... International Journal of Laboratory Hematology 45 (1), 13-19, 2023 | 18 | 2023 |
| Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine AI Gemici, ÖG Sevindik, S Akar, M Tunca Clin Exp Rheumatol 31 (3 Suppl 77), 57-59, 2013 | 18 | 2013 |
| A rare cause of renovascular hypertension: Takayasu arteritis with only renal artery involvement A Borazan, OG Sevindik, D Solmaz, A Gulcu, C Cavdar, A Sifil, A Celik, ... Renal failure 31 (4), 327-331, 2009 | 17 | 2009 |
| The Turkish experience with therapeutic plasma exchange: A national survey S Korkmaz, SS Medeni, F Demirkan, SK Besisik, SA Dadin, GA Cagliyan, ... Transfusion and Apheresis Science 58 (3), 287-292, 2019 | 15 | 2019 |
| Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer A Aksoy, G Artas, OG Sevindik Pakistan journal of medical sciences 33 (3), 560, 2017 | 15 | 2017 |
| Current status of art mobilization in Myeloma OG Sevindik, S Korkmaz, F Altuntas Transfusion and Apheresis Science 56 (6), 850-853, 2017 | 11 | 2017 |
| Nilotinib does not alter the secretory functions of carotid artery endothelial cells in a prothrombotic or antithrombotic fashion A Katgı, ÖG Sevindik, AA Gökbulut, GH Özsan, F Yüksel, ŞM Solmaz, ... Clinical and Applied Thrombosis/Hemostasis 21 (7), 678-683, 2015 | 11 | 2015 |
| Renal and neurological response with eculizumab in a patient with transplant associated thrombotic microangiopathy after allogeneic hematopoietic progenitor cell transplantation ÖG Sevindik, İ Alacacıoğlu, A Katgı, ŞM Solmaz, C Acar, Ö Pişkin, ... Case Reports in Hematology 2015 (1), 425410, 2015 | 11 | 2015 |
| Clinical characteristics and outcomes of COVID-19 in Turkish patients with hematological malignancies S Civriz Bozdağ, G Cengiz Seval, İ Yönal Hindilerden, F Hindilerden, ... Turkish Journal of Hematology 39 (1), 2022 | 10 | 2022 |
| Eltrombopag for the treatment of immune thrombocytopenia: the Aegean Region of Turkey experience F Özdemirkıran, B Payzın, HD Kiper, S Kabukçu, GA Çağlıyan, ... Turkish Journal of Hematology 32 (4), 323, 2015 | 10 | 2015 |
| Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid B Akinci, C Terzi, G Sevindik, F Yuksel, UA Tunc, S Tunali, S Yesil Journal of Diabetes and its Complications 28 (6), 844-849, 2014 | 10 | 2014 |
| A Comparison of Fresenius Com. Tec cell and Spectra Optia cell separators for autologous and allogeneic stem cell collections: single center experience S Solmaz, S Kahraman, OG Sevindik, C Acar, M Turkyilmaz, I Alacacioglu, ... Indian Journal of Hematology and Blood Transfusion 34, 677-683, 2018 | 9 | 2018 |
| A single center cohort of 40 severe COVID-19 patients who were treated withconvalescent plasma A Gemici, H Bilgen, C Erdoğan, A Kansu, O Olmuşçelik, HS Beköz, ... Turkish Journal of Medical Sciences 50 (8), 1781-1785, 2020 | 8 | 2020 |
| Prognostic factors in elderly patients with diffuse large B-cell lymphoma and their treatment results S ADIYAMAN, İ ALACACIOĞLU, A Danyeli, D Turkyilmaz, O Sevindik, ... Turkish Journal of Hematology 36 (2), 2019 | 8 | 2019 |
| Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma AP Ercetin, MA Ozcan, S Aktas, F Yuksel, SM Solmaz, GO Sevindik, ... Experimental Hematology 44 (4), 223-230, 2016 | 8 | 2016 |
